Literature DB >> 21756514

Distinguishing tuberculosis from Mycobacterium avium complex disease using an interferon-gamma release assay.

S W Ra1, J Lyu, C-M Choi, Y-M Oh, S-D Lee, W S Kim, D S Kim, T S Shim.   

Abstract

SETTING: The QuantiFERON-TB Gold (QFT-G) test can be used to distinguish between tuberculosis (TB) and non-tuberculous mycobacterial disease, but a high background TB infection rate may pose a problem. Although the QuantiFERON-TB (QFT) test, the first-generation QFT-G test, employs a non-specific PPD antigen, avium sensitin is also used as a stimulating antigen.
OBJECTIVE: To evaluate the utility of these two interferon gamma release assays (IGRAs), QFT-G and QFT, and the tuberculin skin test (TST), to differentiate TB from Mycobacterium avium complex (MAC) disease in an intermediate TB burden country.
METHODS: We compared the diagnostic performance of these three tests in 38 prospectively enrolled patients with TB and 40 with MAC lung disease.
RESULTS: The TST yielded positive results in 70.6% of TB and 47.5% of MAC patients; the proportions were respectively 89.5% and 34.3% for QFT-G and 86.8% and 35.3% for QFT. The three tests were of similar accuracy, sensitivity and specificity in diagnosing TB.
CONCLUSION: Our findings indicate that the TST and IGRAs could not discriminate between active TB and MAC disease or latent TB infection in a TB-endemic area.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21756514     DOI: 10.5588/ijtld.10.0485

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  7 in total

1.  Evaluation of antigen-specific immunoglobulin g responses in pulmonary tuberculosis patients and contacts.

Authors:  Yun-Gyoung Hur; Ahreum Kim; Young Ae Kang; An Sik Kim; Dae Yeon Kim; Yeun Kim; Youngmi Kim; Hyeyoung Lee; Sang-Nae Cho
Journal:  J Clin Microbiol       Date:  2015-01-14       Impact factor: 5.948

2.  Selective expansion of polyfunctional pathogen-specific CD4(+) T cells in HIV-1-infected patients with immune reconstitution inflammatory syndrome.

Authors:  Yolanda D Mahnke; Jamieson H Greenwald; Rebecca DerSimonian; Gregg Roby; Lis R V Antonelli; Alan Sher; Mario Roederer; Irini Sereti
Journal:  Blood       Date:  2012-01-04       Impact factor: 22.113

3.  Latent and active tuberculosis: evaluation of injecting drug users.

Authors:  Mojgan Mamani; Mohammad Mahdi Majzoobi; Saadat Torabian; Ronak Mihan; Kamyab Alizadeh
Journal:  Iran Red Crescent Med J       Date:  2013-09-05       Impact factor: 0.611

4.  Comparing the Differential Diagnostic Values of 18F-Alfatide II PET/CT between Tuberculosis and Lung Cancer Patients.

Authors:  Xiaoqing Du; Yu Zhang; Liping Chen; Baoming Mi; Qingjun You; Yuping Xu; Donghui Pan; Weixing Wan; Min Yang; Chunjing Yu
Journal:  Contrast Media Mol Imaging       Date:  2018-02-19       Impact factor: 3.161

5.  Levels of TB-IGRA may help to differentiate between intestinal tuberculosis and Crohn's disease in patients with positive results.

Authors:  Yujie Zhao; Meilin Xu; Liang Chen; Zhanju Liu; Xiaomin Sun
Journal:  Therap Adv Gastroenterol       Date:  2020-05-18       Impact factor: 4.409

6.  Non-tuberculous mycobacteria and the performance of interferon gamma release assays in Denmark.

Authors:  Thomas Stig Hermansen; Vibeke Østergaard Thomsen; Troels Lillebaek; Pernille Ravn
Journal:  PLoS One       Date:  2014-04-04       Impact factor: 3.240

7.  Interferon Gamma Release Assays in Patients with Respiratory Isolates of Non-Tuberculous Mycobacteria - a Preliminary Study.

Authors:  Ewa Augustynowicz-Kopeć; Izabela Siemion-Szcześniak; Anna Zabost; Dorota Wyrostkiewicz; Dorota Filipczak; Karina Oniszh; Dariusz Gawryluk; Elżbieta Radzikowska; Damian Korzybski; Monika Szturmowicz
Journal:  Pol J Microbiol       Date:  2019
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.